Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

European CHMP Adopts Negative Opinion on Aztreonam Lysine
Gilead, 03/20/09

Gilead Sciences, Inc. announced that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, has adopted a negative opinion on the company's Marketing Authorisation Application for aztreonam lysine 75 mg powder and solvent for nebuliser solution in the European Union. Aztreonam lysine is an investigational therapy in development for people with cystic fibrosis who have pulmonary Pseudomonas aeruginosa infection.

Today in Marketing/Media/ROI...keeping you current

Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol
Alcon, 12/15/09

Hospira Buys Infection Control Vendor
HealthDataManagement, 12/11/09

Mediware Makes Two Buys
HealthDataManagement, 12/10/09

 See all of Marketing/Media/ROI

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address